Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Rapid Diagnostic Test for Hepatitis C Developed with Scrapbooking Tool

By LabMedica International staff writers
Posted on 17 Jun 2014
Scientists have used a novel approach to develop a paper-based multiplex diagnostic immunoassay that could help curb the hepatitis C pandemic.

For patients already diagnosed with Hepatitis C virus (HCV), the US Food and Drug Administration (FDA) approved two new treatments in late 2013, and others are on the way. More...
Scientists Xuan Mu, Zhi Zheng, and colleagues, of the Chinese Academy of Medical Sciences (Beijing, China), are solving another critical problem—identifying the millions more who unknowingly have the virus and pass it on. They point out that although HCV infects an estimated 150 million people worldwide, current diagnostic testing involves initial screening then a costly second test for confirmation. The extra office visits, money, and time required for definitive diagnosis means that many people are missed as they cannot or do not follow through.

To make diagnosis much more accessible, the researchers applied the recent development of inexpensive paper-based medical technologies to immunoassay detection of human IgG anti-HCV. In a new report they present a novel approach: taking example from the popular scrapbooking pastime, they used a flower-shaped metal paper-puncher on nitrocellulose paper subtrate. This solved the problem of patterning the highly flammable nitrocellulose—without using heat. The flower shape itself provides multiple testing zones, enabling development of a multiplex test. The immunoassays can be conducted such that both HCV tests can be conducted simultaneously on one patient sample on a single flower-shaped paper – at lower cost and in minutes instead of hours.

The work highlights the potential of microfluidic paper-based immunoassays in tackling the diagnostic challenge for the HCV pandemic as well as other diseases. Xuan M., et al. described the new test in the American Chemical Society journal Analytical Chemistry, May 5, 2014, online, ahead of print.

Related Links:

Chinese Academy of Medical Sciences



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.